Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Infinityon Oct 09, 2022 11:56am
216 Views
Post# 35014797

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:The 2nd PP

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:The 2nd PPScience First,  As I have mentioned in my previous post,  I have no problem with the PP.  I do believe the timing of the second follow up PP is to benefit a select few of friends and family Accredited investors.  The second follow up PP could have been easily done after the BTD or even AA is in the bags as originally forecasted by the Management.  These select "Accredited investors"  can purchase one share + one tradeable warrant at $0.25.  Turn around and sell the warrant at close to $ 0.12 will reduce their holding cost of one share at $0.12.    agree I could be off on the selling price of warrant, I am just using an approximation based on current values. NOW.  Please try and explain how this does NOT benefit the select few Accredited investors. 

I sincerely beleive that this Management have a good product and have done incredible amount of work in bringing this product to the current.  Otherwise, I would not be an investor that is a NO BRAINER.    However, I also believe they have been very fairly compensated with salaries, Perqs etc..  The crux of the issue there is no real BOARD Of Directors Governing this company.  
<< Previous
Bullboard Posts
Next >>